Precision Oncology: Translating Discovery to the Clinic | EK45



Sessions

Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma

Speaker(s):

An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells

Speaker(s):

The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.

Speaker(s):

Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma

Speaker(s):

Autologous culture method for precision medicine

Speaker(s):
  • Yao Tang, PhD, University of Maryland School of Medicine

Unraveling the Molecular Determinants of Keloid Formation and Variable Effects of Steroid Treatment using Patient Derived Keloid Fibroblasts

Speaker(s):

Lineage Plasticity: Lessons from Prostate Cancer

Speaker(s):

Welcoming Remarks and Keynote Address

Chair(s):

Pre-Clinical Approaches to Cancer Precision Medicine

Speaker(s):

Clinical Genomics iconClinical Genomics

Preview Available

Clinical Genomics

Co-Chair(s):